Flamel Technologies S.A. (AVDL) CEO Michael S. Anderson Purchases 4,000 Shares
Flamel Technologies S.A. (NASDAQ:AVDL) CEO Michael S. Anderson acquired 4,000 shares of the firm’s stock in a transaction dated Tuesday, September 12th. The stock was bought at an average price of $9.80 per share, with a total value of $39,200.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Flamel Technologies S.A. (NASDAQ AVDL) traded up 0.22% during midday trading on Thursday, reaching $9.22. The company had a trading volume of 127,033 shares. Flamel Technologies S.A. has a 12 month low of $8.14 and a 12 month high of $14.15. The firm’s 50-day moving average price is $9.04 and its 200 day moving average price is $9.83. The firm has a market capitalization of $369.57 million, a PE ratio of 9.74 and a beta of 1.39.
Flamel Technologies (NASDAQ:AVDL) last released its earnings results on Tuesday, August 8th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.14. Flamel Technologies had a return on equity of 29.84% and a net margin of 21.13%. The company had revenue of $46.30 million for the quarter, compared to the consensus estimate of $45.17 million. The company’s quarterly revenue was up 19.0% on a year-over-year basis. Equities analysts anticipate that Flamel Technologies S.A. will post $1.16 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Flamel Technologies S.A. (AVDL) CEO Michael S. Anderson Purchases 4,000 Shares” was posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/09/14/flamel-technologies-s-a-avdl-ceo-michael-s-anderson-purchases-4000-shares.html.
Large investors have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. bought a new position in Flamel Technologies during the 1st quarter worth approximately $3,654,000. US Bancorp DE bought a new position in Flamel Technologies during the 1st quarter worth approximately $121,000. Acadian Asset Management LLC lifted its holdings in Flamel Technologies by 9.7% during the 2nd quarter. Acadian Asset Management LLC now owns 1,672,207 shares of the company’s stock worth $18,444,000 after buying an additional 147,907 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its holdings in Flamel Technologies by 27.9% during the 2nd quarter. State of New Jersey Common Pension Fund D now owns 42,090 shares of the company’s stock worth $464,000 after buying an additional 9,175 shares during the last quarter. Finally, Trexquant Investment LP lifted its holdings in Flamel Technologies by 30.7% during the 2nd quarter. Trexquant Investment LP now owns 30,500 shares of the company’s stock worth $336,000 after buying an additional 7,169 shares during the last quarter. 69.09% of the stock is currently owned by institutional investors.
Several brokerages have recently issued reports on AVDL. Roth Capital set a $15.00 price objective on Flamel Technologies and gave the company a “buy” rating in a research note on Wednesday, August 9th. Langenberg & Company reiterated a “buy” rating and issued a $30.00 price objective (up previously from $27.00) on shares of Flamel Technologies in a research note on Thursday, September 7th. Ladenburg Thalmann Financial Services lifted their price objective on Flamel Technologies from $27.00 to $30.00 in a research note on Thursday, September 7th. Finally, Zacks Investment Research upgraded Flamel Technologies from a “hold” rating to a “buy” rating and set a $12.00 price objective for the company in a research note on Monday, July 17th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $19.83.
About Flamel Technologies
Flamel Technologies SA is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its polymer based technology. The Company has a balanced business model consisting of an Unapproved Marketed Drugs (UMDs) business with over two approved products in the United States, Bloxiverz (neostigmine methylsulfate injection) and Vazculep (phenylephrine hydrochloride injection) that are marketed; a branded pediatric business, and a branded business, focusing on the development of products utilizing Flamel’s drug delivery platforms.
Receive News & Ratings for Flamel Technologies S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flamel Technologies S.A. and related companies with MarketBeat.com's FREE daily email newsletter.